Senores Pharmaceuticals IPO GMP, Grey Market Premium Today

Senores Pharmaceuticals IPO GMP, Grey Market Premium Today

Senores Pharmaceuticals IPO's GMP is ₹125 on December 18, 2024. If you add this to the IPO price, which is ₹391, you get an estimated listing price of ₹516. This means there's a potential gain of 32% per share.The GMP is updated daily, and recently it's been towards the lower side.Keep an eye on daily updates to see how the IPO price is trending.

Check Live IPO : GMP List 👈

Upcoming

Senores Pharmaceuticals IPO GMP Today is - ₹125


Last Updated - 18 December, 2024 9:10 pm
IPO dekho.in

Senores Pharmaceuticals IPO
GMP

GMP - ₹125 👈
38
Lot Shares
₹14,858
Lot Price
₹4,750
Expected Profit
Expected Profit

Price :

₹391

GMP :

₹125 👈

Expected Listing :

391+125 = ₹516

Expected Profit :

32% 👈

Rating :

★★★☆☆

Senores Pharmaceuticals IPO Expected Profit

Number Of LotsLot SharesLot PriceLot ProfitLot Expected Listing
138₹14,858₹4,750 ₹19,608
276₹29,716₹9,500 ₹39,216
3114₹44,574₹14,250 ₹58,824
4152₹59,432₹19,000 ₹78,432
5190₹74,290₹23,750 ₹98,040
6228₹89,148₹28,500 ₹1,17,648
7266₹1,04,006₹33,250 ₹1,37,256
8304₹1,18,864₹38,000 ₹1,56,864
9342₹1,33,722₹42,750 ₹1,76,472
10380₹1,48,580₹47,500 ₹1,96,080
11418₹1,63,438₹52,250 ₹2,15,688
12456₹1,78,296₹57,000 ₹2,35,296
13494₹1,93,154₹61,750 ₹2,54,904

Senores Pharmaceuticals IPO Dates


  • Open Date
    20 December, 2024
  • Close Date
    24 December, 2024
  • Allotment Date
    26 December, 2024
  • Refund Date
    27 December, 2024
  • Shares Credit Date
    27 December, 2024
  • Listing Date
    30 December, 2024

Senores Pharmaceuticals IPO GMP - ₹125

GMP DateIPO PriceIPO GMPEstimated Listing PriceIPO Gain %Last Updated
December 18, 2024₹391₹125₹51632%18 December, 2024 9:10 pm

Senores Pharmaceuticals Day-Wise IPO GMP Trend

[.]

Senores Pharmaceuticals IPO GMP Grey Market Premium FAQs

What is Senores Pharmaceuticals IPO GMP Today?

Senores Pharmaceuticals IPO GMP is ₹125 as of today.


What is Senores Pharmaceuticals IPO Expected Returns?

Senores Pharmaceuticals IPO Expected Returns is 32%.

Leave a Comment

Your email address will not be published. Required fields are marked *